A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Clinical trial NCT01018173 · COMPLETED
Trial details
- NCT number
- NCT01018173
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-01-01
- Enrollment
- 2118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.